These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 22916723)

  • 1. Fractalkine gene receptor polymorphism in patients with multiple sclerosis.
    Arli B; Irkec C; Menevse S; Yilmaz A; Alp E
    Int J Neurosci; 2013 Jan; 123(1):31-7. PubMed ID: 22916723
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The association of V249I and T280M fractalkine receptor haplotypes with disease course of multiple sclerosis.
    Stojković L; Djurić T; Stanković A; Dinčić E; Stančić O; Veljković N; Alavantić D; Zivković M
    J Neuroimmunol; 2012 Apr; 245(1-2):87-92. PubMed ID: 22261545
    [TBL] [Abstract][Full Text] [Related]  

  • 3. T280M and V249I polymorphisms of fractalkine receptor CX3CR1 and ischemic cerebrovascular disease.
    Hattori H; Ito D; Tanahashi N; Murata M; Saito I; Watanabe K; Suzuki N
    Neurosci Lett; 2005 Feb; 374(2):132-5. PubMed ID: 15644279
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased expression of the chemokine fractalkine in Crohn's disease and association of the fractalkine receptor T280M polymorphism with a fibrostenosing disease Phenotype.
    Brand S; Hofbauer K; Dambacher J; Schnitzler F; Staudinger T; Pfennig S; Seiderer J; Tillack C; Konrad A; Göke B; Ochsenkühn T; Lohse P
    Am J Gastroenterol; 2006 Jan; 101(1):99-106. PubMed ID: 16405540
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Arylsulfatase a gene polymorphisms in relapsing remitting multiple sclerosis: genotype-phenotype correlation and estimation of disease progression.
    Baronica KB; Mlinac K; Ozretić D; Vladić A; Bognar SK
    Coll Antropol; 2011 Jan; 35 Suppl 1():11-6. PubMed ID: 21648305
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD24 as a genetic modifier of disease progression in multiple sclerosis in Argentinean patients.
    González SJ; Rojas JI; Redal MA; Patrucco L; Correale J; Argibay PF; Cristiano E
    J Neurol Sci; 2011 Aug; 307(1-2):18-21. PubMed ID: 21641619
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lack of association between monocyte protein-1 (MCP-1) -2518 A>G chemoattractant and C-C chemokine receptor 2 (CCR2) Val64Ile polymorphisms and multiple sclerosis in a Tunisian population.
    Messadi A; Fekih-Mrissa N; Kallel A; Bouguerra C; Sediri Y; Zaweli J; Laayouni S; Nciri B; Yedeas M; Mrissa R; Jemaa R; Kaabachi N; Gritli N
    J Clin Neurosci; 2010 Oct; 17(10):1311-3. PubMed ID: 20637631
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CCR5-Delta32 genetic polymorphism associated with benign clinical course and magnetic resonance imaging findings in Brazilian patients with multiple sclerosis.
    Kaimen-Maciel DR; Reiche EM; Brum Souza DG; Frota Comini ER; Bobroff F; Morimoto HK; Ehara Watanabe MA; Carvalho De Oliveira J; Matsuo T; Lopes J; Donadi EA
    Int J Mol Med; 2007 Sep; 20(3):337-44. PubMed ID: 17671738
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polymorphisms of Fractalkine receptor CX3CR1 and plasma levels of its ligand CX3CL1 in colorectal cancer patients.
    Dimberg J; Dienus O; Löfgren S; Hugander A; Wågsäter D
    Int J Colorectal Dis; 2007 Oct; 22(10):1195-200. PubMed ID: 17611763
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CRYAB promoter polymorphisms: influence on multiple sclerosis susceptibility and clinical presentation.
    Stoevring B; Frederiksen JL; Christiansen M
    Clin Chim Acta; 2007 Jan; 375(1-2):57-62. PubMed ID: 17010329
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Apolipoprotein E genotype does not associate with disease severity measured by Multiple Sclerosis Severity Score.
    Guerrero AL; Laherrán E; Gutiérrez F; Martín-Polo J; Iglesias F; Alcázar C; Peralta J; Rostami P
    Acta Neurol Scand; 2008 Jan; 117(1):21-5. PubMed ID: 17883422
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TNF-alpha promoter polymorphisms in multiple sclerosis: no association with -308 and -238 alleles, but the -857 alleles in associated with the disease in Turkish patients.
    Akcali A; Pehlivan S; Pehlivan M; Sever T; Akgul P; Neyal M
    Int J Immunogenet; 2010 Apr; 37(2):91-5. PubMed ID: 20082645
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic association between polymorphisms in the BTG1 gene and multiple sclerosis.
    Camiña-Tato M; Morcillo-Suárez C; Navarro A; Fernández M; Horga A; Montalban X; Comabella M
    J Neuroimmunol; 2009 Aug; 213(1-2):142-7. PubMed ID: 19515430
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Candidate gene analysis of SPARCL1 gene in patients with multiple sclerosis.
    Scalabrini D; Fenoglio C; Scarpini E; De Riz M; Comi C; Venturelli E; Cortini F; Piola M; Villa C; Naldi P; Monaco F; Bresolin N; Galimberti D
    Neurosci Lett; 2007 Oct; 425(3):173-6. PubMed ID: 17825989
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of common polymorphisms in the fractalkine receptor (CX3CR1) with obesity.
    Sirois-Gagnon D; Chamberland A; Perron S; Brisson D; Gaudet D; Laprise C
    Obesity (Silver Spring); 2011 Jan; 19(1):222-7. PubMed ID: 20523302
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic association of CASP8 polymorphisms with primary progressive multiple sclerosis.
    Camiña-Tato M; Fernández M; Morcillo-Suárez C; Navarro A; Julià E; Edo MC; Montalban X; Comabella M
    J Neuroimmunol; 2010 May; 222(1-2):70-5. PubMed ID: 20363033
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Progression of multiple sclerosis is associated with exon 1 CTLA-4 gene polymorphism.
    Bilińska M; Frydecka I; Noga L; Dobosz T; Zołedziewska M; Suwalska K; Tutak A; Pokryszko-Dragan A
    Acta Neurol Scand; 2004 Jul; 110(1):67-71. PubMed ID: 15180809
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fractalkine receptor polymorphism may not be associated with the development and clinical course of ulcerative colitis.
    Gokcan H; Yurtcu E; Selcuk H; Sahin FI
    Bosn J Basic Med Sci; 2015 May; 15(2):73-7. PubMed ID: 26042517
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gender-specific influence of the chromosome 16 chemokine gene cluster on the susceptibility to Multiple Sclerosis.
    Galimberti D; Scalabrini D; Fenoglio C; De Riz M; Comi C; Venturelli E; Cortini F; Piola M; Leone M; Dianzani U; D'Alfonso S; Monaco F; Bresolin N; Scarpini E
    J Neurol Sci; 2008 Apr; 267(1-2):86-90. PubMed ID: 17967467
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HLA-DRB1*1501, -DQB1*0301, -DQB1*0302, -DQB1*0602, and -DQB1*0603 alleles are associated with more severe disease outcome on MRI in patients with multiple sclerosis.
    Zivadinov R; Uxa L; Bratina A; Bosco A; Srinivasaraghavan B; Minagar A; Ukmar M; Benedetto Sy; Zorzon M
    Int Rev Neurobiol; 2007; 79():521-35. PubMed ID: 17531857
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.